Key facts
- This page summarizes Richard A. Meier's Form 5 filing for BIOMARIN PHARMACEUTICAL INC (BMRN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Feb 2026, 19:00.
Richard A. Meier - 31 Dec 2025 Form 5 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)
- Reporting relationship
- Director
- Issuer ticker
- BMRN
- Reported as of
- 31 Dec 2025
- Net transaction value
- $0
- SEC form
- 5
- Accepted by SEC
- 13 Feb 2026, 19:00:05 UTC
- Prior SEC filing
- 22 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tae Sang Yoo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Richard A. Meier filed Form 5 for BIOMARIN PHARMACEUTICAL INC (BMRN) on 13 Feb 2026.
Change
- Previous filing in this sequence was filed on 22 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 5 disclosures.
Reporting Owners (1)
CIK 0001227305
Primary reporting owner
MEIER RICHARD A
- Relationship
- Director
- Address
- C/O BIOMARIN PHARMACEUTICAL INC., 770 LINDARO STREET, SAN RAFAEL
- Signature
- /s/ Tae Sang Yoo, Attorney-in-Fact
- Signature date
- 13 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BMRN
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -500
- Change %
- -0.39%
- Price
- $0.000000
- Shares after
- 126,926
- Date
- 30 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.